You are here

  • Home
  • Archive
  • Volume 11, Issue 4
  • Review: low-molecular-weight heparin prevented recurrent VTE more than oral anticoagulants in patients with cancerCommentary

Article info

Article menu
Download PDFPDF
Treatment
Review: low-molecular-weight heparin prevented recurrent VTE more than oral anticoagulants in patients with cancer

Authors

View Full Text

Citation

Howard AF
Review: low-molecular-weight heparin prevented recurrent VTE more than oral anticoagulants in patients with cancer
Evidence-Based Nursing 2008;11:117.

Publication history

  • First published September 24, 2008.
Online issue publication 
August 31, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 RCN Publishing Company Limited and BMJ Publishing Group Ltd